Article

Band 3 protein clustering on human erythrocytes promotes binding of naturally occurring anti-band 3 and anti-spectrin antibodies.

Institute of Biochemistry, Swiss Federal Institute of Technology, ETH-Zentrum, CH 8092 Zurich, Switzerland.
Experimental Gerontology (impact factor: 3.74). 11/2000; 35(8):1025-44. pp.1025-44
Source: PubMed

ABSTRACT Recognition of senescent and oxidatively stressed human erythrocytes appeared to be initiated by band 3 clustering, followed by bivalent binding of naturally occurring anti-band 3 autoantibodies (anti-band 3 NAbs), and complement deposition. The number of RBC-associated anti-band 3 NAbs was, however, low compared to the total amount of IgG that bound in vitro to RBC containing band 3 oligomers. This implied the involvement of yet other types of NAb, among which we focussed on anti-spectrin NAbs, since eluates from RBC of thalassemic patients contained these NAbs. Binding of affinity-purified anti-band 3 and anti-spectrin NAbs was studied to RBC on which band 3 oligomers were generated by exoplasmic cross-linking. This pretreatment increased binding not only of (125)I-iodinated anti-band 3, but also of anti-spectrin NAbs by 7-10-fold at 0 degrees C in the presence of nearly physiological IgG and HSA concentrations. Binding of anti-spectrin NAbs was not to spectrin as judged from surface-labeling of RBCs that were pretreated with cross-linker. Binding was dose and time dependent in both cases. Moreover, binding of anti-spectrin NAbs was not competed by high concentrations of anti-band 3 NAbs and anti-spectrin NAbs even stimulated binding of anti-band 3 F(ab')(2) by 30%. This suggests that anti-spectrin NAbs bound to band 3 or a protein associated with band 3 by virtue of their inherent polyreactivity.

0 0
 · 
0 Bookmarks
 · 
15 Views
  • Source
    Article: Biomarker analysis of stored blood products: emphasis on pre-analytical issues.
    [show abstract] [hide abstract]
    ABSTRACT: Millions of blood products are transfused every year; many lives are thus directly concerned by transfusion. The three main labile blood products used in transfusion are erythrocyte concentrates, platelet concentrates and fresh frozen plasma. Each of these products has to be stored according to its particular components. However, during storage, modifications or degradation of those components may occur, and are known as storage lesions. Thus, biomarker discovery of in vivo blood aging as well as in vitro labile blood products storage lesions is of high interest for the transfusion medicine community. Pre-analytical issues are of major importance in analyzing the various blood products during storage conditions as well as according to various protocols that are currently used in blood banks for their preparations. This paper will review key elements that have to be taken into account in the context of proteomic-based biomarker discovery applied to blood banking.
    International Journal of Molecular Sciences 01/2010; 11(11):4601-17. · 2.60 Impact Factor

Keywords

0 degrees C
 
125)I-iodinated anti-band 3
 
affinity-purified anti-band 3
 
anti-band 3 autoantibodies
 
anti-band 3 NAbs
 
anti-spectrin NAbs
 
band 3
 
band 3 clustering
 
band 3 oligomers
 
Binding
 
bivalent binding
 
exoplasmic cross-linking
 
human erythrocytes
 
physiological IgG
 
pretreated
 
RBC-associated anti-band 3 NAbs
 
RBCs
 
thalassemic patients
 
time dependent
 
total amount